| Literature DB >> 17999706 |
Gjalt-Jorn Y Peters1, Gerjo Kok, Charles Abraham.
Abstract
AIMS: The health hazards and prevalence of ecstasy use have been documented in two decades of research, but no review reporting on potentially modifiable antecedents of use is available. The aim of this study was to integrate systematically research identifying cognitive correlates of ecstasy use. Such research has the potential to identify targets for evidence-based interventions designed to discourage use.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17999706 PMCID: PMC2253702 DOI: 10.1111/j.1360-0443.2007.02041.x
Source DB: PubMed Journal: Addiction ISSN: 0965-2140 Impact factor: 6.526
Quantitative studies into the determinants of using ecstasy and measures used.
| No. | Sample details | n | Age | % ♀ | Relevant variables | I | R |
|---|---|---|---|---|---|---|---|
| UK, before July 2002 Polydrug users | 364 | 19 | 44% | Negative mood function scale | 3 | 5 | |
| Social function scale | 5 | 5 | |||||
| Negative effects | 4 | 5 | |||||
| Other functions (9 functions) | 1 | 5 | |||||
| Extent of peer use | 1 | 4 | |||||
| Partner/best friend use | 1 | 2 | |||||
| Intensity of use | 1 | – | |||||
| UK, before March 1998 Alcohol and drug users | 100 | 19 | 45% | Mood function scale | 3 | 5 | |
| Social/contextual function scale | 5 | 5 | |||||
| Negative effects/events scale | 3 | 5 | |||||
| Extent of peer use | 1 | 5 | |||||
| Intention | 1 | 7 | |||||
| Intensity of use | 1 | – | |||||
| Frequency of use | 1 | – | |||||
| [26a] | UK, March 1992 Students | 186 | 19–25 | 58% | Attitudes | 6 | 7 |
| Subjective norms | 1 | 7 | |||||
| Perceived behavioural control | 6 | 7 | |||||
| Behavioural beliefs (17) | 2 | 19 | |||||
| Normative beliefs (5) | 2 | 19 | |||||
| Control beliefs (8) | 2 | 19 | |||||
| Intention to use ecstasy | 4 | 7 | |||||
| [26b] | UK, mid-1996 Club members | t1: 203 t2: 123 | 23 | 41% | Attitudes | 8 | 7 |
| Normative influences | 13 | 7 | |||||
| Perceived behavioural control | 1 | 7 | |||||
| Self-efficacy | 1 | 7 | |||||
| Behavioural beliefs | 13 | 7 | |||||
| Control beliefs | 6 | 7 | |||||
| Intention | 3 | 7 | |||||
| Behaviour (longitudinal) | 4 | – | |||||
| Netherlands, 2000, 2001 Party attendants | 844 | 22 | 33% | Negative outcome expectancies | 11 | 2 | |
| Enhancement outcome expectancies | 3 | 2 | |||||
| Euphoria outcome expectancies | 4 | 2 | |||||
| Sex outcome expectancies | 4 | 2 | |||||
| Dancing outcome expectancies | 3 | 2 | |||||
| Insight outcome expectancies | 4 | 2 | |||||
| Communication outcome expectancies | 4 | 2 | |||||
| Whether ecstasy was currently used | 1 | 2 | |||||
| UK t1: October 1994–1995 t2: May1995–1996 Students | t1: 461 t2: 136 | 19–22 19–22 | 55% 65% | Attitude | 2 | 7 | |
| Injunctive norms | 6 | 7 | |||||
| Perceived behavioural control | 8 | 7 | |||||
| Descriptive norms | 2 | 6 | |||||
| Moral norm | 1 | 7 | |||||
| Intention | 1 | 8 | |||||
| Behaviour (longitudinal) | 1 | 8 | |||||
| UK, before 2003 College students | 657 | 19 | 55% | Frequency of past use | 1 | 7 | |
| Intentions to use | 1 | 9 | |||||
| Normative influence (friends’ use) | 1 | 6 | |||||
| Beliefs about ecstasy use (7 beliefs) | 1 | 5 | |||||
| UK | t1: 84 t2: 32 | 20 | 74% | Attitude | 10 | 8 | |
| Subjective norm | 2 | 8 | |||||
| Perceived behavioural control over obtaining ecstasy | 3 | 8 | |||||
| Perceived behavioural control over taking ecstasy | 4 | 8 | |||||
| Intention | 5 | 8 | |||||
| Habit | 2 | 8 | |||||
| Specific attitudinal beliefs (13 beliefs) | 1 | 5 | |||||
| Behaviour (longitudinal) | 1 | 2 | |||||
| the Netherlands, 2001–2002 | 490 | 22 | 34% | Energy motives | 4 | 5 | |
| Euphoria motives | 3 | 5 | |||||
| Self-insight motives | 2 | 5 | |||||
| Sociability/flirtatiousness motives | 8 | 5 | |||||
| Sexiness motives | 4 | 5 | |||||
| Coping motives | 3 | 5 | |||||
| Conformism motives | 4 | 5 | |||||
| Perceived positive effects | 24 | 2 | |||||
| Perceived negative effects | 11 | 2 | |||||
| Perceived friends’ use | 1 | 5 | |||||
| Frequency of ecstasy use | 1 | 5 | |||||
| UK | 200 | 21 | 66% | Attitude | 5 | ? | |
| Subjective norm | 5 | 5 | |||||
| Perceived behavioural control over obtaining ecstasy | 3 | 7 | |||||
| Perceived behavioural control over taking ecstasy | 11 | ? | |||||
| Intention | 6 | 7 | |||||
| Habit | 2 | 7 | |||||
| USA Club rave attendees | 70 | 20 | 47% | Risk associated with using ecstasy once or twice | 1 | 4 | |
| Risk associated with using ecstasy regularly | 1 | 4 | |||||
| Harmful short-term physical effects | 1 | 4 | |||||
| Harmful long-term physical effects | 1 | 4 | |||||
| Harmful short-term psychological effects | 1 | 4 | |||||
| Harmful long-term psychological effects | 1 | 4 | |||||
| Positive physical effects | 1 | 4 | |||||
| Positive psychological effects | 1 | 4 | |||||
| Ecstasy use within the past 12 months | 1 | 2 |
No. = number in reference list, I = number of items used to measure variable, R = number of scale points on response scale of each item.
Longitudinal design.
Effect sizes of predictors of ecstasy use and intention to use.
| Association with behaviour | Association with intention | ||||
|---|---|---|---|---|---|
| Variable type | Compound or expectancy | k | r+ | k | r+ |
| Attitude | Attitude [C] | 5 | 0.53 (L) | 5 | 0.63 (L) |
| Positive expectancies | Social function [C] | 4 | 0.09 | 2 | 0.30 (M) |
| Produces a positive mood state | 3 | 0.12 (S) | 2 | 0.28 (M) | |
| Mood function [C] | 4 | 0.20 (S) | 1 | 0.41 (L) | |
| Helps lose weight | 2 | 0.09 | 1 | 0.08 | |
| Enhances sex | 3 | 0.11 (S) | |||
| Helps stay awake | 3 | 0.08 | |||
| Helps keep fit | 1 | 0.14 (S) | 1 | 0.22 (S) | |
| Enhances insight/openness | 2 | 0.18 (S) | |||
| Helps to relax/helps coping | 2 | 0.08 | |||
| Produces excitement | 1 | 0.31 (M) | |||
| Produces intoxication | 1 | 0.19 (S) | |||
| Eases after-effects | 1 | 0.15 (S) | |||
| Improves other drugs' effects | 1 | 0.11 (S) | |||
| Is conforming to peers | 1 | 0.05 | |||
| Helps work | 1 | 0.05 | |||
| Negative expectancies | Short-term negative effects [C] | 4 | −0.47 (L) | ||
| Produces mood swings | 1 | −0.34 (M) | 2 | −0.31 (M) | |
| Leads on to more frequent use | 1 | −0.30 (M) | 2 | −0.39 (L) | |
| Produces mental side-effects | 1 | −0.24 (M) | 2 | −0.40 (L) | |
| Leads on to ‘worse’ drugs | 1 | −0.23 (S) | 2 | −0.31 (M) | |
| Produces physical side-effects | 1 | −0.18 (S) | 2 | −0.39 (L) | |
| Makes one unhealthy | 1 | −0.18 (S) | 2 | −0.30 (M) | |
| Produces depression | 1 | −0.18 (S) | 2 | −0.28 (M) | |
| Produces lethargy | 1 | −0.05 | 2 | −0.20 (S) | |
| Produces addiction | 1 | −0.32 (M) | 1 | −0.12 (S) | |
| Leads to death | 1 | −0.30 (M) | 1 | −0.32 (M) | |
| Produces paranoia | 1 | −0.27 (M) | 1 | −0.26 (M) | |
| Makes one feel run down | 1 | −0.17 (S) | 1 | −0.25 (M) | |
| Subjective injunctive norm | Subjective norms (approval) [C] | 5 | 0.39 (L) | 5 | 0.52 (L) |
| Best friends' approval | 1 | 0.36 (M) | 1 | 0.25 (M) | |
| Partners approval | 1 | 0.15 (S) | 1 | 0.30 (M) | |
| Parents' approval | 1 | 0.10 (S) | 1 | 0.01 | |
| Health experts' approval | 1 | 0.09 | 1 | 0.00 | |
| Other ecstasy users' approval | 1 | 0.07 | 1 | 0.08 | |
| Subjective descriptive norm | Subjective norms (descriptive) [C] | 1 | 0.52 (L) | 1 | 0.63 (L) |
| Perceived peer use | 2 | 0.39 (L) | 1 | 0.43 (L) | |
| Perceived use in close relatives | 2 | 0.21 (S) | |||
| Perceived best friend/partner use | 1 | 0.37 (L) | |||
| Perceived behavioural control | PBC [C] | 3 | 0.33 (M) | 3 | 0.52 (L) |
| PBC (over obtaining ecstasy) | 2 | 0.20 (M) | 2 | 0.25 (M) | |
| PBC (over taking ecstasy) | 2 | 0.01 | 2 | −0.03 | |
| Being with friends who use | 1 | 0.45 (L) | 2 | 0.62 (L) | |
| Going out dancing | 1 | 0.41 (L) | 2 | 0.67 (L) | |
| Being offered ecstasy | 1 | 0.40 (L) | 2 | 0.59 (L) | |
| Ecstasy being available | 1 | 0.40 (L) | 2 | 0.57 (L) | |
| Cheap ecstasy | 1 | 0.19 (M) | 2 | 0.54 (L) | |
| Having alcohol | 1 | −0.02 | 2 | 0.10 (S) | |
| PBC (over | 1 | −0.06 | 1 | 0.07 | |
| Needing to lose weight | 1 | −0.05 | 1 | 0.00 | |
| Needing to exercise | 1 | −0.01 | 1 | 0.05 | |
| Miscellaneous | Habit [C] | 2 | 0.45 (L) | 2 | 0.46 (L) |
| Moral norm [C] | 2 | −0.28 (M) | 2 | −0.31 (M) | |
| Denial of negative consequences | 1 | 0.17 (S) | 1 | 0.18 (S) | |
| Anticipated regret | 1 | −0.11 (S) | 1 | −0.22 (S) | |
[C] = compound construct, k = no. of samples, r+ = weighed average correlation, (S) = small, (M) = medium, (L) = large effect size magnitude according to Cohen [42]. PBC: perceived behavioural control.
Significant and non-significant predictors of user group (user group had six levels in study [29] and two levels in study [33]).
| Variable | Study | Significance | Association | Effect size |
|---|---|---|---|---|
| Perceived use by friends | [ | < 0.001 | Positive | M |
| Anticipated regret (‘use would induce guilt’) | [ | < 0.001 | Negative | M |
| Is hard to resist | [ | < 0.001 | Positive | M |
| Moral norm (‘ecstasy use is immoral’) | [ | < 0.05 | Negative | S |
| Perceived availability of ecstasy | [ | < 0.05 | Positive | S |
| Is bad for one's physical health | [ | None | – | – |
| Is bad for one's mental health | [ | None | – | – |
| Subjective norm (approval) | [ | None | – | – |
| Harmful long-term physical effects | [ | < 0.01 | Negative | M |
| Risk associated with using regularly | [ | < 0.01 | Negative | M |
| Risk association with using once or twice | [ | < 0.05 | Negative | M |
| Harmful long-term psychological effects | [ | < 0.05 | Negative | M |
| Harmful short-term physical effects | [ | None | – | – |
| Harmful short-term psychological effects | [ | None | – | – |
| Positive physical effects | [ | None | – | – |
| Positive psychological effects | [ | None | – | – |
S = small, M = medium, effect size magnitude according to Cohen [42].
Search terms used in PsycINFO (equivalent terms used in corresponding fields in MedLine and ERIC) [query in words, as corresponding to ‘concepts’ column, in brackets].
| No. | Concept | Operationalization | Fields |
|---|---|---|---|
| 1 | Language | (English) or (Dutch) | Language |
| 2 | Publication type | (journal*) or (peer-reviewed-journal) | Publication type |
| 3 | Publication date | > 1980 | Publication year |
| 4 | Ecstasy | (clubdrug*) or (club near drug*) or (dance near drug*) or (dancedrug*) or (party near drug*) or (partydrug*) or (xtc) or (mdma) or (methylenedioxymethamphetamine) or (‘3,4-methylenedioxymethamphetamine’) or (ecstasy) | Title, abstract, keywords |
| 5 | Theoretical | (theor*) or (attitud*) or (motivat* near functio*) or (mode*) or (norm*) or (perceived near control) or (pbc) or ('social cognitive’) or (self adj efficacy) or (stages near change) or (perceived adj (harm or risk or functions)) or (functional) or (outcome adj (expectancies or expectations)) or (sct) or (tpb) or (patter*) or (psychosoc*) or (health adj belief adj model) or (hbm) | Title, abstract, keywords |
| 6 | Determinants | (determin*) or (facto*) or (variabl*) or (parameter*) or (reason*) or (caus*) or (motiv*) or (incentive*) or (correlat*) or (antecedent*) or (character*) | Title, abstract, keywords |
| 7 | Initiation | (start*) or (commenc*) or (originat*) or (onset) or (initiat*) or (instigat*) or ((use) not (user)) or (using) or (usage) or (establish*) | Title, abstract, keywords |
| 8 | Maintenance | (maint*) or (sustain*) or (continu*) or (uphold*) or (persist*) or (further*) or (prolong*) | Title, abstract, keywords |
| 9 | Cessation | (end*) or (stop*) or (discontinu*) or (terminat*) or (ceas*) or (cessat*) or (abstain*) or (abstin*) or (quit*) or (remiss*) or (resolut*) or (recover*) | Title, abstract, keywords |
| 10 | Harm reduction | (harm or risk or damage or casualt*) and (reduc* or manag* or limit* or minimi*) | Title, abstract, keywords |
| 11 | Excluded | ((treatment not (‘not in treatment’ or ‘non-treatment’ or ‘non- treatment’ or ‘no treatment’)) or rat or rats or mouse or mice or animal or monkey* or pigeon* or spectro* or cardio* or seroton* or dopamin* or neurotransm* or receptor* or psychiatr* or psychopath* or cell* or diagnos*) | Anywhere |
| 12 | Inclusion | #1 and #2 and #3 [Language and Publication Type and Publication Date] | – |
| 13 | Behaviour | #7 or #8 or #9 or #10 [Initiation or Maintenance or Cessation or Harm reduction] | – |
| 14 | Empirical* | #6 near #13 [Determinants near Behaviour] | – |
| 15 | Final query* | #12 and #4 near (#5 or #14) not #11 [Inclusion and Ecstasy near (Theoretical or Empirical) not Excluded] | – |
When executed, the query consisted of one command; therefore the use of the ‘near’-operator was valid here.
Search procedure, number of resulting hits, and results of each step.
| Step | Activity | Number of resulting publications |
|---|---|---|
| 1 | Input of query at 20 August 2007 in PsycINFO (162), MedLine (194) and ERIC (11) | 367 |
| 2 | Removal of duplicate records (83) | 284 |
| 3 | Removal of records about publications that (entries were removed in this order): | |
| 3.1 | studied biological variables (e.g. sequelae of ecstasy use; 75) | 209 |
| 3.2 | did not study ecstasy use or a related behaviour (such as trying out ecstasy, ceasing use, changing use patterns, or applying harm reduction practices; 32) | 177 |
| 3.3 | studied variables that cannot be changed using a health promotion intervention (e.g. sex, ethnicity or religion; 68) | 109 |
| 3.4 | studied ecstasy use as an independent variable in a multivariate or longitudinal analysis (22) | 87 |
| 3.5 | did not employ quantitative methods (e.g. qualitative studies; 30) | 57 |
| 3.6 | did not study behaviour or cognitions (25) | 32 |
| 3.7 | studied a ‘non-normal’ subpopulation or gathering data from samples inseparably encompassing these subpopulations (e.g. dependent participants, patients or delinquents) | 18 |
| 3.8 | were not published in a peer-reviewed journal (3) | 15 |
inclusion of these subpopulations would restrict generalization of the results to the target population of the current study (i.e. the average adolescent; see [12,55]).
this demand of drug specificity is necessary because previous research has shown that beliefs about drugs can vary between different drugs [56], rendering aggregation questionable.